Workflow
Patient - centric cardiorenal care
icon
搜索文档
scPharmaceuticals to Announce Second Quarter 2025 Financial Results After the Market Close on August 7, 2025
GlobeNewswire News Room· 2025-07-31 20:01
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs. Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially imp ...
scPharmaceuticals Announces Participation in Three Upcoming Investor Conferences
GlobeNewswire News Room· 2025-05-01 20:01
公司动态 - scPharmaceuticals Inc 宣布首席执行官 John Tucker 将参加多个投资者会议 包括 Citizens Life Sciences Conference、Craig-Hallum 22nd Annual Institutional Investor Conference 和 H C Wainwright 3rd Annual BioConnect Investor Conference [1][4] - 公司将在这些会议上进行演讲 具体时间为 5 月 7 日 9:30 ET、5 月 20 日 10:00 ET 和 5 月 28 日 [1][4] - 演讲内容可通过公司官网投资者关系板块的"News & Events"栏目观看网络直播 [1] 公司概况 - scPharmaceuticals Inc 是一家专注于心肾健康领域的制药公司 致力于通过以患者为中心的创新来改变心肾医疗 [2] - 公司总部位于马萨诸塞州伯灵顿 [3] - 公司使命是通过创新、综合的治疗方案推进心肾护理 解决未满足的患者需求 [2] 发展战略 - 公司目标是成为以患者为中心的心肾护理领域领先倡导者 通过专业、多学科的方法推动全球健康改善 [3] - 公司正在扩大业务范围 提供综合疗法和产品 以满足多样化的医疗需求 并可能改善患者生活 [3]